Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
govindaraj sarma
Your search for
Govinda Rai Sarma
retrieved no results
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
N Engl J Med. 2017.
PMID: 28845751
Free article.
Clinical Trial.
Transcriptional Fluctuations Govern the Serum-Dependent Cell Cycle Duration Heterogeneities in Mammalian Cells.
Govindaraj V, Sarma S, Karulkar A, Purwar R, Kar S.
Govindaraj V, et al.
ACS Synth Biol. 2022 Nov 18;11(11):3743-3758. doi: 10.1021/acssynbio.2c00347. Epub 2022 Nov 3.
ACS Synth Biol. 2022.
PMID: 36325971
Item in Clipboard
Targeting BRF2: insights from in silico screening and molecular dynamic simulations.
Rathore AS, Gupta KK, Govindaraj SK, Ajmani A, Arivalagan J, Anto RJ, Kalishwaralal K, Chandran SA.
Rathore AS, et al.
J Biomol Struct Dyn. 2023 Sep 13:1-13. doi: 10.1080/07391102.2023.2256884. Online ahead of print.
J Biomol Struct Dyn. 2023.
PMID: 37705251
Targeting BRF2 using these promising compounds may offer a new therapeutic approach to sensitize cancer cells to ferroptosis and apoptosis.Communicated by Ramaswamy H. Sarma....
Targeting BRF2 using these promising compounds may offer a new therapeutic approach to sensitize cancer cells to ferroptosis and apoptosis.C …
Item in Clipboard
Cite
Cite